Loading...
Incannex Healthcare Inc (IXHL) is not a good buy for a beginner, long-term investor with $50,000-$100,000 to invest. The stock exhibits weak technical indicators, poor financial performance, and lacks positive catalysts or strong trading signals. Additionally, the recent reverse stock split to meet Nasdaq compliance raises concerns about the company's stability and growth potential.
The stock is in a bearish trend with MACD below 0 and negatively expanding, RSI indicating oversold conditions at 16.151, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support levels are at 0.179 and 0.142, with resistance at 0.298 and 0.335. Overall, the technical indicators suggest a weak price trend.
NULL identified. There are no significant trading trends, and no recent congress trading data or influential figure transactions.
The company announced a 1-for-30 reverse stock split to meet Nasdaq compliance, which may indicate financial instability. Additionally, the financial performance shows a complete drop in revenue (-100% YoY) and gross margin (-100% YoY), with a negative net income of -6.52M.
In Q2 2026, the company reported a 100% YoY drop in revenue and gross margin, with net income at -6.52M (up 10.64% YoY). EPS dropped significantly by -93.94% YoY to -0.02, indicating poor financial health.
No data available for analyst ratings or price target changes.
